Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:57 PM
Ignite Modification Date:
2025-12-24 @ 10:57 PM
NCT ID:
NCT06449469
Eligibility Criteria:
Inclusion Criteria:
* Patients who underwent successful TAVI according to Valve Academic Research Consortium (VARC)-2 criteria
* Residing in Denmark
* Provided written informed consent
Exclusion Criteria:
* Atrial fibrillation or any other indication for lifelong oral anticoagulant therapy
* Patient deemed not suitable for DOAC treatment because of previous life-threatening or major bleeding, e.g. intracranial haemorrhage or major gastrointestinal bleeding
* Patients with severe renal insufficiency (eGFR \<30 mL/min/1.73 m2)
* Patient with absolute indication for anti-thrombotic therapy, e.g. recent PCI
* Iodine contrast allergy or other condition that prohibits CT imaging
* Age \<18 years
* Women of childbearing potential, pregnant or nursing
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06449469
Study Brief:
Protocol Section:
NCT06449469